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Malaria,  HIV,  and tuberculosis  (TB)  collectively  account  for several  million  deaths  each  year,  with  all
three  ranking  among  the  top  ten  killers  in low-income  countries.  Despite  being  caused  by  very different
organisms,  malaria,  HIV,  and TB present  a suite  of  challenges  for mathematical  modellers  that  are  par-
ticularly  pronounced  in  these  infections,  but represent  general  problems  in infectious  disease  modelling,eywords:
odelling
IV
uberculosis
alaria
and  highlight  many  of  the  challenges  described  throughout  this  issue.  Here,  we describe  some  of  the uni-
fying  challenges  that  arise  in modelling  malaria,  HIV,  and  TB,  including  variation  in  dynamics  within  the
host,  diversity  in the  pathogen,  and  heterogeneity  in  human  contact  networks  and  behaviour.  Through
the  lens  of these  three  pathogens,  we provide  speciﬁc  examples  of  the  other  challenges  in  this  issue  and
discuss  their  implications  for  informing  public  health  efforts.
©  2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-NDntroduction
Taken together, malaria, HIV, and tuberculosis (TB) infect more
han a third of the global population and are responsible for
lmost three million deaths each year (WHO, 2013a,b,c). Sub-
tantial investments in the prevention and treatment of these
hree pathogens have led to signiﬁcant reductions in morbidity
nd mortality worldwide over the past century (WHO, 2013a,b,c).
hroughout this advancement, mathematical modelling has been
 key tool in helping to understand transmission dynamics and
n predicting the impact of control programmes (Anderson et al.,
991; Dye et al., 2013; Dye and Williams, 2010; Garnett et al.,
011; Macdonald, 1956; Mal, 2011; Stover, 2000). For example, vec-
or control as a way to effectively reduce malaria was  recognised
hrough population-level compartmental modelling more than 100
ears ago (Ross, 1910) and the importance of CD4+ lymphocytes
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as sites for HIV proliferation was  predicted using simple models
nearly two decades ago (Ho et al., 1995). Although these and other
models have provided valuable insights, incomplete understanding
of the biology and transmission of these three pathogens remains
a signiﬁcant hurdle to the development of useful mathematical
frameworks; new theoretical approaches and improved integra-
tion of a variety of different kinds of data are needed. Here, we
use malaria, HIV, and TB to examine unifying mathematical chal-
lenges across the ﬁeld of infectious disease modelling, despite their
biological differences, to provide concrete examples reﬂecting gen-
eral problems in the ﬁeld, and to consider the role that modelling
can play to inform public health efforts. We  focus our attention on
relatively simple models, exposing the data gaps and uncertain-
ties that create fundamental challenges in designing basic model
structures and parameterisation, rather than on large-scale simula-
tions, which often suffer from the same knowledge gaps as simpler
frameworks but are less transparent and can be difﬁcult to inter-
pret. Indeed, we propose that, in general, while simple models
often do not capture the biological complexities of these infections,
more complex models may  lack the data for parameterisation and
validation, presenting a paradox for modellers. We  identify chal-
lenges in the following main areas: variation in dynamics within
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Pathogen dynamics within individual infections. Grey shaded areas denote
periods where the infection is asymptomatic, either due to chronicity in malaria (A)
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cnd HIV (B) or latency as in TB (C). Despite a lack of symptoms, particularly during
hronic infections, individuals may  still be infectious and contribute to spread of the
athogen.
he host, pathogen genetic diversity, and heterogeneity in human
ontact networks and behaviour. Throughout, we  reference speciﬁc
odelling challenges addressed in depth elsewhere in this issue
referred to by article and challenge number).
. Understanding infection dynamics in the host
The majority of models designed to inform policy on malaria,
IV, and TB are based upon population-level compartmental mod-
ls, which generally assume single categories of infected and
mmune people, a ﬁxed rate of recovery, and simple estimates
or the duration of infectiousness (Dowdy et al., 2013; Johnson
nd White, 2011; Reiner et al., 2013). The most commonly used
usceptible-Infected-Recovered (SIR) compartmental models were
eveloped to study outbreaks of acute immunising infections
mong immunologically naïve populations, often describing the
otential for an epidemic through summary statistics such as the
eproductive number, R0. These assumptions must be modiﬁed for
ndemic pathogens exhibiting variable infection dynamics in the
ost (Article 15, Gog et al., 2015) Challenge #2), heterogeneous
mmunological states between hosts (Article 11, Wikramartna
t al., 2015, Challenge #4), and signiﬁcant spatial and temporal vari-
tion in risk (Article 20, Riley et al., 2015, Challenge #1). At the level
f an individual, all three of these pathogens cause a wide range
f clinical and infection outcomes related to host genetic hetero-
eneity, coinfection, or previous exposure (Article 11, Wikramartna
t al., 2015, Challenge #5), and this creates extensive variability in
oth the infection length and the dynamics of infectiousness of an
ndividual (Fig. 1). Therefore, assumptions of a constant rate of loss
f infectiousness and a uniform recovery rate may  not adequately
epresent the infectious population underlying transmission.
In malaria, sustained parasite proliferation in the blood by
he most virulent species Plasmodium falciparum may  lead to a
hronic phase of highly variable intensity and duration (Bull et al.,s 10 (2015) 102–107 103
1998; Newbold et al., 1997) (Fig. 1A). Repeated and simultaneous
infections with different antigenically diverse parasites lead to a
“semi-immune” status in older children and adults in endemic
regions that is protective against severe disease (Bull et al., 2005);
however, little is known about how patterns of exposure alter the
distribution of chronic periods and the extent of the infectious pop-
ulation (Hansen and Buckee, 2013; Churcher et al., 2013; Killeen
et al., 2006; Lin et al., 2014; Lindblade et al., 2013) (Article 8,
Cunniffe et al., 2015, Challenge #6). Most infected individuals in
endemic regions harbour multiple clones and have a complex his-
tory of exposure (Article 15, Gog et al., 2015, Challenge #5), and
although compartments can be added to SIR frameworks to account
for the accumulation of multiple exposures, basic parameters are
lacking to describe these individuals including relative infectious-
ness to mosquitoes, susceptibility to new infections, and rates of
clearance of infection (Article 11, Wikramartna et al., 2015, Chal-
lenge #5; Article 18, Pellis et al., 2015, Challenge #1). Ultimately,
this means that the probability of a mosquito bite leading to infec-
tion is poorly deﬁned, so feedback between human and mosquito
components of the model may  be mis-speciﬁed, complicating esti-
mates of the impact of different interventions (Hansen and Buckee,
2013).
Infection with HIV is incurable, which removes the need to esti-
mate heterogeneous parameters of recovery and immunity, but
complex within-host dynamics lead to variable infectious periods
(Fig. 1B). An HIV infection is characterised by an initial acute phase
with rapid pathogen growth, followed by stabilisation at a set point
viral load that plays a critical role in determining the duration
of the chronic period (Fraser et al., 2007) but is highly heteroge-
neous among individuals, likely the result of complex and poorly
understood interplay between the host immune system and the
virus (Perreau et al., 2013) (Article 13, Metcalf et al., 2015a, Chal-
lenge #3). As a result, the progression from chronic, low-density
infections to full-blown AIDS and the variable length of chronic
infections remain difﬁcult to incorporate within epidemiological
models (Fig. 1B). In particular, including individual heterogeneity
in the rate of transition through these different states of disease and
infectiousness will require a better understanding of the complex
mechanisms determining the dynamics of HIV within an individual.
The dominant source of variability in the within-host dynamics
of tuberculosis infections results from heterogeneity in the timing
of active disease. Most new infections result in an asymptomatic
“latent” infection, with innate immunity controlling bacillary
growth in the lung (Ernst, 2012) (see Orme, 2014 for a novel view
on latent infections). Although latent infection confers immunity
to active disease arising from reinfection (Andrews et al., 2012),
a small proportion of those who are latently infected progress to
active disease (Ernst, 2012). The lack of data on the distribution of
times between becoming infectious to self-cure, disease or diag-
nosis, with indirect estimates suggesting that this period can range
from a few months to several years (Tiemersma et al., 2011), makes
realistic incorporation of the initiation of active disease into models
difﬁcult (Article 22, Lessler et al., 2015, Challenge #3) (Fig. 1C). It
is clear that TB progresses much more rapidly in HIV-positive than
in HIV-negative individuals (Lawn and Churchyard, 2009), empha-
sising the important and understudied dynamics that may  result
from co-infection (Article 13, Metcalf et al., 2015a, Challenge #2).
Heterogeneous within-host dynamics for all three infections
make it difﬁcult to establish the timing and duration of latent or
chronic infection periods, where transmission potential may  differ
signiﬁcantly from acute infection. As a result, modelling the impact
of individual-level interventions on population-level transmission
is challenging. Given the paucity of data on the dynamics of nat-
ural infections in endemic regions (Article 22, Lessler et al., 2015,
Challenge #3), standard model frameworks frequently assume that
varying previous exposure does not alter distributions of infectious
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eriods in malaria, that infectiousness is not related to within-
ost infection dynamics for HIV, and that TB progression rates are
andomly distributed. Note that we have focused here on simple
odels, but the same uncertain parameters governing within-host
ynamics must also be estimated in more complex frameworks
Article 15, Gog et al., 2015, Challenge #7; Article 23, De Angelis,
015). A more thorough understanding of within host infection
ynamics of malaria, HIV, and TB will lead to a more accurate assess-
ent of the infectious populations responsible for transmission,
 crucial quantity when evaluating interventions to inform policy
ecisions.
. Incorporating pathogen genetic variation
Although very different organisms cause malaria, HIV, and TB,
athogen genetic diversity is a major obstacle to the design and
se of vaccines and therapeutics for all three, hindering control and
limination prospects. Any model incorporating multiple pathogen
trains faces the challenge of keeping track of people infected with,
nd immune to, different strains (Article 11, Wikramartna et al.,
015), as well as deﬁning the antigenic relationships between
trains, their rate of genetic change (Articles 13, Metcalf et al.,
015a, and 14, Frost, 2015), genetic bottlenecks resulting from
ransmission (Article 15, Gog et al., 2015, Challenge #1), and the
onsequences and frequency of superinfection (Article 15, Gog
t al., 2015, Challenge #5; Article 16, Roberts, 2015, Challenge #6).
The malaria parasite exhibits remarkable genetic diversity,
specially among gene families such as the var genes, which are
nvolved in phenotypic variation within the host and associated
ith disease outcome (Johnston et al., 2013). Diversity among these
ene families is continually generated through frequent recombi-
ation, a mode of diversiﬁcation that is difﬁcult to accommodate
ithin modelling frameworks (Article 14, Frost, 2015, Challenge
5). Indeed, malaria parasite genomic diversity is so great in
ndemic regions that we still lack adequate genotype markers,
aking it nearly impossible to track genotypes in a population
r to sensitively establish the multiplicity of infection (Manske
t al., 2012). Model complexities arising from frequent superinfec-
ion include a rapid increase in the number of categories necessary
o account for individuals harbouring varying numbers of geno-
ypes and insufﬁcient data to accurately assign immunological
elationships against parasite genotypes. Most models incorporat-
ng superinfection assume independence of strains with a ﬁxed
ime since infection for each genotype, neglecting the impact of
uperinfection on duration of infection and relative infectiousness
o mosquitoes (Article 15, Gog et al., 2015, Challenge #5; Article 16,
oberts, 2015, Challenge #6). In particular, parameterising the out-
ome of competition between strains within a single host plays an
mportant role for understanding how variation created in a single
nfection carries over to the next human host, as the mosquito vec-
or acts as a critical genetic bottleneck (Conway et al., 1999) (Article
5, Gog et al., 2015).
Rapid diversiﬁcation within and between hosts poses signiﬁcant
hallenges for HIV, where every possible point mutation may  arise
n a single day during HIV proliferation (Perelson et al., 1997), and
his complex within-host diversity is subsequently shaped through
ressure from the host’s immune system and drug treatment (Arti-
le 15, Gog et al., 2015, Challenge #2). On a population level,
he antigenic Env glycoprotein exhibits extensive diversity, which
ncreases by 1–2% every year (Novitsky et al., 2009). Modellers
ust decide whether to include both within-host and population-evel models of viral diversiﬁcation. In the absence of an explicit
ithin-host component, assumptions must be made about how
iversity generated during an individual infection relates to the
ubset of viral genomes that are successfully transmitted (Articles 10 (2015) 102–107
14, Frost, 2015, Challenge #7). Despite a recent rise in interest, there
remains insufﬁcient data about the relationship between within
host diversiﬁcation and transmission for HIV, so current theoret-
ical frameworks make strong assumptions about the bottleneck
imposed by transmission (Article 15, Gog et al., 2015, Challenge
#1) and the impact of superinfection (Article 15, Gog et al., 2015,
Challenges #5 and #6).
Although Mycobacterium tuberculosis is one of the least diverse
bacterial pathogens, among the few of its loci that vary are genes
that harbour mutations coding for drug resistance (McGrath et al.,
2014). Evidence that different drug resistant strains and lineages
have different mutation rates, different ﬁtness costs and elicit dif-
ferent levels of immunity suggests the epidemiological dynamics
of drug resistant TB will require a better understanding of the biol-
ogy of strain differences and the inclusion of multiple strains in
models (Ford et al., 2013) (Article 14, Frost, 2015, Challenge #6).
Selection within the host and resulting emergence of drug resis-
tance at a population level is not well understood although the
relationship between pathogen diversity and the immune system
is known to be critical. Models must be adapted to include evo-
lution and dynamics of pathogen genotypes across scales in order
to understand the emergence and maintenance of diverse popula-
tions of Mycobactrium tuberculosis (Article 13, Metcalf et al., 2015a,
Challenge #4). Consequences for TB epidemiology depend on mea-
suring and understanding ﬁtness across pathogen generations, for
which little conclusive data exists (Dye and Williams, 2009). Cha-
racterising the impact of genetic diversity on the ﬁtness of drug
resistant TB strains will allow for incorporation into strain models.
Pathogen genetic diversity is often ignored within prevailing
models of malaria, HIV, and TB despite the variety of strains and
genotypes known to circulate at the population level. As antigenic
variation among, and competition between, strains will alter their
frequency in the population and transmission overall, the inclu-
sion of multiple genetic variants will be important for many policy
questions, particularly in relation to drug resistance.
3. Accounting for heterogeneous contact rates and changes
in behaviour
The inclusion of realistic human behaviours relating to the
spread of disease and the efﬁcacy of interventions remains a chal-
lenge for many infectious disease models (Articles 18, Pellis et al.,
2015, and 20, Riley et al., 2015), but represents a particular prob-
lem for malaria, HIV, and TB. Heterogeneities from dynamic contact
networks, such as sexual contacts in HIV and indirect contacts in
vector-borne infections like malaria, as well as a wide range of
behaviours that inﬂuence exposure and effectiveness of treatment,
are challenging to accurately parameterise (Kato et al., 2013; Miller,
2009) (Article 18, Pellis et al., 2015; Article 19, Ball, 2015, Challenges
#3 and #4). Travel of infected individuals, which is often difﬁ-
cult to measure, spreads infections within and between countries
and regions (Article 4, Funk, 2015, Challenge #6; Article 20, Riley
et al., 2015, Challenge #3), jeopardising the sustainability of con-
trol programmes and prospects for elimination (Buckee et al., 2013)
(Article 3, Klepac, 2015). In all three cases, vulnerable groups may
exhibit fundamentally different epidemiological dynamics than the
general population, and must be modelled and parameterised sep-
arately.
Malaria requires a vector for transmission, in contrast to many
pathogens including HIV and TB, so contacts between people are by
deﬁnition indirect (Fig. 2A). The variability of vector habitats and
hosts means that malaria prevalence shows strong geographical
heterogeneity (Article 6, Hollingsworth, 2015, Challenge #2), with
transmission being focused in so-called “hotspots” or in mobile
populations that are exposed to infection through forestry or
L.M. Childs et al. / Epidemic
Fig. 2. Networks for spread of infection. Malaria (A) transmission between individ-
uals (circles) requires the mosquito vector, resulting in “hotspots” for transmission
driven by heightened exposure to malaria-infected mosquitoes in certain regions
(red shaded circles). For HIV (B) and TB (C) transmission occurs between individ-
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sals  in a directed fashion indicated by arrows. Dotted black lines indicate spatially
eparated populations. (For interpretation of the references to colour in this ﬁgure
egend, the reader is referred to the web version of this article.)
gricultural work (Bousema et al., 2010; Ahmed et al., 2013; Carrara
t al., 2013). These heterogeneities are obscured by prevalence
stimates that are generally derived on large spatial scales, and
ecrease the predictive power of mathematical models of trans-
ission (Hasibeder and Dye, 1988) (Article 20, Riley et al., 2015,
hallenges #1 and #5). Complex dynamics may  emerge from the
nteraction of seasonal travel for agricultural work and seasonal
hanges in the environmental drivers of mosquito populations,
nd are difﬁcult to accommodate in current model frameworks.
dditional variation arises as many individuals do not seek treat-
ent or use preventive measures like bed nets despite widespread
vailability, which makes it difﬁcult to predict the impact of inter-
entions and the timelines required for control and elimination.
HIV spreads unevenly through communities deﬁned by distinct
ehaviours (Fig. 2B), such as sex workers, men  who  have sex with
en, and injecting drug users (Gupta et al., 1989; Eaton et al., 2011;
arnett and Anderson, 1994; Tanser et al., 2011; Zuma et al., 2005).
easuring and quantifying the heterogeneities in these networks
emains challenging (Article 21, Eames, 2015); for example, part-
ership acquisition rates are needed to generate realistic contact
etworks in models, but generally only cross-sectional data is avail-
ble on the total number of partners each individual has over speciﬁed time period (Abuelezam et al., 2013). These different
ocial groups may  also exhibit systematic variations in behaviours
ffecting treatment-seeking, adherence to treatment, and expo-
ure, such as the use of condoms or the dropout of people over thes 10 (2015) 102–107 105
so-called treatment cascade (Losina et al., 2010), which can further
alter the risk and course of infection. Even when detailed data is
available, the incorporation of temporally changing interactions is
challenging to include and nearly impossible to accurately param-
eterise. Static and highly simpliﬁed contact patterns are often used
in the absence of data on the complex and dynamic network struc-
tures that actually underlie HIV transmission.
For the spread of TB (Fig. 2C), many occupational and
behavioural risk factors that enhance transmission have been
clearly identiﬁed, focusing attention on the homeless and sub-
stance users in low burden settings in the US and Europe (Lonnroth
et al., 2009), and on health care workers, drivers of crowded
vehicles, prisoners, migrants, those working in mines and resi-
dents of overcrowded slums in high burden countries (Bates et al.,
2004). Collecting reliable data on patterns of movement and migra-
tion is difﬁcult, particularly across borders among refugee and
migrant communities, who are at high risk of infection (Article
22, Lessler et al., 2015). Among those infected, behaviour strongly
inﬂuences the duration of infectiousness because treatment seek-
ing depends on access to care and recognition of symptoms, which
overlap with other chronic lung conditions including smoking
(Storla et al., 2008). All of these factors lead to difﬁculty identi-
fying the infectious population, while the lack of granularity in
incidence and prevalence data and the inability to directly capture
values for behavioural parameters make valid parameterisation
of models challenging (Article 23, De Angelis, 2015, Challenge
#4).
Despite the known importance of behaviour on disease preva-
lence, the extent of the infectious population, and the emergence of
drug resistance, the social factors that drive individual behaviours
are poorly understood. What level of behaviour change is neces-
sary to alter an epidemic (Article 4, Funk, 2015, Challenge #1) and
the level of detailed data required to measure this change (Article 4
Challenges #2 and #4) remain open questions. Social and spatial
aspects are often not accounted for in traditional model frame-
works, which generalise behaviour on a population level, and this
not only distorts epidemic dynamics but also underestimates re-
exposure and reinfection among groups most at risk (Perkins et al.,
2013) (Articles 16, Roberts, 2015, and 19, Ball, 2015). Furthermore,
most models treat behaviour as static, although modiﬁcations of
behaviour are likely to change as perception of risk shifts along
with transmission. Incorporating variation in behaviour over the
course of an intervention or in the case of multiple interventions is
essential if models are to reliably predict the impact of the inter-
ventions or calculate their cost-effectiveness (Dye and Williams,
2008; Long and Stavert, 2013) (Article 2, Klepac, 2015, Challenge
#5).
Conclusion
As we  move towards control and potentially elimination for
malaria, HIV, and TB, mathematical models provide a powerful
framework to consider the possible impact of interventions, iden-
tify areas where further empirical work is needed, and focus on
the important policy and research questions. Critical knowledge
gaps for the effective application of models for policy include
spatial and temporal variations in disease prevalence and transmis-
sion intensity, host–pathogen interactions and infection outcome,
and human behaviour. Most importantly, better communication
between modellers and experimentalists or ﬁeld workers will be
needed to reﬁne the questions, determine which data are most
important and must urgently needed, and to ensure that the ana-
lytical work leads to better policy and better control of all three
infections (Article 2, Cunniffe et al., 2015; Metcalf et al., 2015b,
Challenges #4 and #6).
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